dsm-firmenich, a leading innovator in health, nutrition, and beauty, is delighted to announce that it has gained approval for an additional four human milk oligosaccharide (HMO) ingredients for use as nutritive substances in infant formula products in Australia and New Zealand. The approval follows the company’s successful application – submitted by Glycom A/S* – to the Food Standards Australia New Zealand (FSANZ). dsm-firmenich is the first HMO manufacturer to apply and obtain approval for the … [Read more...] about Nurturing the future: dsm-firmenich announces approval of HMO ingredients for infant nutrition innovation in Australia and New Zealand